The University of Vermont

Publication List

Selected Publications



  • S. Morley
    Relapse prevention: still neglected after all these years.
    Pain, 134 (3): 239-240, 2008. FULL TEXT PDF

  • M. Naylor, F. Keefe, B. Brigidi, S. Naud, J. Helzer
    Therapeutic Interactive Voice Response for chronic pain reduction and relapse prevention.
    Pain, 134 (3): 335-345, 2008. FULL TEXT PDF

  • Newhouse, Paul A; Potter, Alexandra; Singh, Abhay.
    Effects of nicotinic stimulation on cognitive performance
    Current Opinion in Pharacology. 2004, 4:36-46 FULL TEXT PDF

  • Naylor M.R., Helzer E.J, Naud S,. Keefe F J.
    Automated Telephone as an Adjunct for the Treatment of Chronic Pain: A Pilot Study".
    Journal of Pain, 3 (6): 2002, 429-438

  • Newhouse, Paul A; Potter, Alexandra; Kelton, Megan; Corwin, June.
    Nicotinic treatment of Alzheimer's disease.
    Biological Psychiatry. Vol 49(3) Feb 2001, 269-278. FULL TEXT PDF

  • van Dyck, Christopher H; Newhouse, Paul; Falk, William E; Mattes, Jeffrey A.
    Extended-release physostigmine in Alzheimer disease: A multicenter, double-blind, 12-week study with dose enrichment.
    Archives of General Psychiatry. Vol 57(2) Feb 2000, 157-164.

  • Newhouse PA. Krishnan KR. Doraiswamy PM. Richter EM. Batzar ED. Clary CM.
    A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients.
    Journal of Clinical Psychiatry. 61(8):559-68, 2000 Aug.

  • Rusted JM. Newhouse PA. Levin ED.
    Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer's disease and Parkinson's disease.
    Behavioural Brain Research. 113(1-2):121-9, 2000 Aug.

  • Kelton MC. Kahn HJ. Conrath CL. Newhouse PA.
    The effects of nicotine on Parkinson's disease.
    Brain & Cognition. 43(1-3):274-82, 2000 Jun-Aug.

  • Newhouse PA. Kelton M.
    Nicotinic systems in central nervous systems disease: degenerative disorders and beyond.
    Pharmaceutica Acta Helvetiae. 74(2-3):91-101, 2000 Mar. FULL TEXT PDF

  • Potter A. Corwin J. Lang J. Piasecki M. Lenox R. Newhouse PA.
    Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease.
    Psychopharmacology. 142(4):334-42, 1999 Mar.

  • Newhouse, Paul A.
    Alzheimer's disease and the cholinergic system: An introduction to clinical pharmacological research.
    Heston, Leonard L. (Ed). (1997). Progress in Alzheimer's disease and similar conditions. American Psychopathological Association series. (pp. 213-231).

  • Newhouse PA. Potter A. Levin ED.
    Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.
    Drugs & Aging. 11(3):206-28, 1997 Sep.

  • Newhouse PA.
    Use of serotonin selective reuptake inhibitors in geriatric depression.
    Journal of Clinical Psychiatry. 57 Suppl 5:12-22, 1996. FULL TEXT PDF

  • Newhouse PA.
    Decoupling motor memory strategies: effects of sleep deprivation and amphetamine.
    International Journal of Neuroscience. 74(1-4):45-54, 1994 Jan-Feb.

  • Newhouse PA. Potter A. Corwin J. Lenox R.
    Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior.
    Neuropsychopharmacology. 10(2):93-107, 1994 Apr. FULL TEXT PDF

  • Newhouse, Paul A; Penetar, David M; Fertig, Joanne B; Thorne, David R; et al.
    Stimulant drug effects on performance and behavior after prolonged sleep deprivation: A comparison of amphetamine, nicotine, and deprenyl.
    Military Psychology. Vol 4(4) 1992, 207-233. FULL TEXT PDF

  • Cochran JC. Thorne DR. Penetar DM. Newhouse PA.
    Parsing attentional components during a simple reaction time task using sleep deprivation and amphetamine intervention.
    Perceptual & Motor Skills. 75(3 Pt 1):675-89,1992 Dec.

  • Newhouse PA. Potter A. Corwin J. Lenox R.
    Acute nicotinic blockade produces cognitive impairment in normal humans.
    Psychopharmacology. 108(4):480-4, 1992. FULL TEXT PDF

  • Newhouse, Paul A; Hughes, John R.
    The role of nicotine and nicotinic mechanisms in neuropsychiatric disease.
    British Journal of Addiction. Vol 86(5) May 1991, 521-525. FULL TEXT PDF

  • Newhouse PA. Sunderland T. Narang PK. Mellow AM. Fertig JB. Lawlor BA. Murphy DL.
    Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's disease.
    Psychoneuroendocrinology. 15(5-6):471-84, 1990. FULL TEXT PDF

  • Sunderland T. Hill JL. Mellow AM. Lawlor BA. Gundersheimer J. Newhouse PA. Grafman JH.
    Clock drawing in Alzheimer's disease. A novel measure of dementia severity.
    Journal of the American Geriatrics Society. 37(8):725-9, 1989 Aug.

  • Newhouse PA. Belenky G. Thomas M. Thorne D. Sing HC. Fertig J.
    The effects of d-amphetamine on arousal, cognition, and mood after prolonged total sleep deprivation.
    Neuropsychopharmacology. 2(2):153-64, 1989 Jun. FULL TEXT PDF

  • Newhouse PA.
    Differential responsivity of mood, behavior, and cognition to cholinergic agents in elderly neuropsychiatric populations.
    Brain Research. 472(4):371-89, 1988 Dec.

  • Newhouse, P.A. Sunderland T. Tariot PN. Weingartner H. Thompson K. Mellow AM. Cohen RM. Murphy DL.
    The effects of acute scopolamine in geriatric depression.
    Archives of General Psychiatry. 45(10):906-12, 1988 Oct. FULL TEXT PDF

  • Newhouse P.A. Sunderland T. Tariot PN. Blumhardt CL. Weingartner H. Mellow A. Murphy DL.
    Intravenous nicotine in Alzheimer's disease: a pilot study.
    Psychopharmacology. 95(2):171-5, 1988. FULL TEXT PDF

  • Newhouse, Paul A; Sunderland, Trey; Tariot, Pierre N; Mueller, Edward A; et al.
    Prolactin response to TRH in Alzheimer's disease and elderly controls.
    Biological Psychiatry. Vol 21(10) Aug 1986, 963-967.

    Last modified September 24 2008 09:28 PM

    Contact UVM © 2009 The University of Vermont - Burlington, VT 05405 - (802) 656-3131